Dr. Pardell is a board-certified psychiatrist and Distinguished Lifetime Fellow of the American Psychiatric Association. He is an honors graduate of the University of Pennsylvania (Magna Cum Laude and Phi Beta Kappa), and the New York University School of Medicine (Alpha Omega Alpha). Dr. Pardell was Chief Resident at St. Luke’s-Roosevelt Hospital Center, NY and a post-doctoral fellow at Columbia University School of Medicine. He completed, with distinction, the Neuroscience Educational Institute Master Pharmacology Program, the Harvard Medical School Berenson-Allen Brain Stimulation Center Fellowship in Transcranial Magnetic Stimulation and Visiting Fellowship in Transcranial Magnetic Stimulation at Duke University School of Medicine. In 2021, Dr. Pardell was elected as the President of the Clinical TMS Society and in 2022, became a founding member of the Foundation for the Advancement of Clinical TMS.

As a highly regarded lecturer, Dr. Pardell has educated fellow physicians and mental health clinicians on the latest pharmacologic and innovative treatments of psychiatric disorders. He was recognized by Castle Connolly as a Top Doctor in the Hudson Valley in the Hudson Valley Magazine in 2010, 2017 and Top Doctor in Castle-Connolly/ US and News and World Report in 2010-2018. Dr. Pardell also had the honor of being acknowledged by his patients with the Patient Choice Award 2011, 2013-2014, 2016 and the Compassionate Doctor Recognition 2011, 2013-2014, 2016 and Vitals On-Time Doctor Award 2014.

We evaluate each patient with an extensive medical and psychiatric history assessment, blood analysis, genetic testing to personalize medication treatment selection. We offer Neurocognitive Testing and QEEG Brain Mapping to assist in diagnosis and treatment direction. We develop an individualized treatment plan which includes: medication management, nutritional and bioidentical hormone supplementation, psychotherapy, career coaching and consulting, Neurofeedback, Biofeedback and Transcranial Magnetic Stimulation (TMS) the breakthrough technology for treatment
resistant depression, anxiety, OCD and more.